1. Home
  2. SELX vs ITRM Comparison

SELX vs ITRM Comparison

Compare SELX & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SELX

Semilux International Ltd. Ordinary Shares

HOLD

Current Price

$0.76

Market Cap

24.0M

Sector

N/A

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.33

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELX
ITRM
Founded
2021
2015
Country
Taiwan
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SELX
ITRM
Price
$0.76
$0.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
201.2K
930.9K
Earning Date
05-08-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,974,593.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$193.01
P/E Ratio
N/A
N/A
Revenue Growth
243.84
N/A
52 Week Low
$0.52
$0.26
52 Week High
$1.85
$1.75

Technical Indicators

Market Signals
Indicator
SELX
ITRM
Relative Strength Index (RSI) 47.95 45.27
Support Level $0.71 $0.31
Resistance Level $0.80 $0.39
Average True Range (ATR) 0.07 0.03
MACD -0.02 0.01
Stochastic Oscillator 22.24 32.08

Price Performance

Historical Comparison
SELX
ITRM

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: